On June 5, 2024 AchilleS Vaccines, a biotech company committed to the sustainable development of safe vaccines and biopharmaceuticals against infectious diseases, reported its rebranding to Contraria Biotech (Press release, AchilleS Vaccines, JUN 5, 2024, View Source [SID1234644781]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The new company name revolves around the key message contained in the old logo. In Latin contraria means antagonist , the two arrows that symbolize the "Contraria" logo are an ideal graphic synthesis to explain the action and functioning of an immuno-drug against a pathogen. The good arrow that breaks the bad one, equal and opposite to it.
Contraria Biotech is thus born , an evolution of the name of the company founded in 2017 that fully reflects the desire to expand its core business, no longer limited to vaccines. Since the dawn of immunological science, vaccines and immunotherapeutics have proven to be the most effective and often synergistic tools against the risks associated with the spread of pathogens. The advent of new technologies, combined with ongoing translational work in the immuno-pharmaceutical field, allow Contraria Biotech to maximize knowledge of the antigen and create both next-generation vaccines and monoclonal antibodies against new and re-emerging pathogens.
The new name and brand well reflect the company’s commitment to designing innovative therapeutic and prophylactic products against some of the primary problems of global health, including the phenomenon of antibiotic resistance. "The Latin contraria also recalls the English contrarian , which means against the trend . It is a name with a universal sound that evokes innovation and courage, two distinctive elements of our company’s DNA on which we want to build our future." Riccardo Baccheschi, CEO of Contraria Biotech .